Hundreds of thousands of Australians who use a certain type of ADHD medication will be forced to use amphetamine-based ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on ...

Instead, participants said, classifying methylphenidate a schedule 6 drug “ negatively impacts on treatment adherence ”. Our medicines regulator, the South African Health Products Regulatory Authority ...

In addition, searches for Biphentin and ADHD, methylphenidate transdermal system and ADHD, and Metadate CD and ADHD were performed following the final search to corroborate findings (no additional ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...